On September 23, 2026, three companies—SSY Group Ltd (02005), CStone Pharmaceuticals-B (02616), and Gushengtang (02273)—filed their latest shareholder interest disclosures.

SSY Group Ltd reported that director Qu Jiguang increased his long position from 1.277 billion shares to 1.278 billion shares, lifting his stake to 43.31% from the previous 43.27%.

CStone Pharmaceuticals-B saw Yang Jianxin raise his long position to 84.7801 million shares from 84.4886 million shares, with his holding percentage rising to 5.31% from the earlier 5.29%.

Gushengtang disclosed that Tu Zhiliang held his long position steady at 82.2022 million shares, unchanged from 82.1934 million shares, maintaining his stake at 35.07%.

Note: Changes in share counts may result from events such as rights issues, share consolidations, or stock splits. Investors should verify against actual circumstances.